Ishares MSCI EUR Fin (EUFN) 17.52 $EUFN Pain or Gain

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ishares MSCI EUR Fin (EUFN) 17.52 $EUFN

Pain or Gain Ahead for Bank ETFs?
Zacks Equity Research - Zacks Investment Research - Fri Apr 08, 12:28PM CDT
The banking sector and the related ETFs are surrounded by perils and possibilities
KRE: 40.53 (-0.57), KBE: 32.24 (-0.53), KBWB: 35.23 (-0.57), EUFN: 17.52 (-0.81)

Materials and Europe: 2 ETFs to Watch on Outsized Volume
Zacks Equity Research - Zacks Investment Research - Fri Mar 11, 7:13AM CST
XME and EUFN saw massive volumes in yesterday trading session.
SPY: 210.07 (-2.01), QQQ: 108.94 (-1.25), DIA: 178.71 (-1.17), EUFN: 17.52 (-0.81), XME: 23.47 (-0.40)

Top ETF Stories of February
Zacks Equity Research - ZACKS - Tue Mar 01, 5:03AM CST
Inside the top ETF stories of February that pulled the strings in the investing world throughout the month.
PTF: 37.85 (-0.59), KRE: 40.53 (-0.57), EFZ: 33.87 (+0.97), BIS: 39.14 (+1.60), DTYL: 82.03 (+0.17), IGV: 105.47 (-1.48), SQQQ: 18.21 (+0.58), GLD: 121.74 (+0.49), FXY: 90.60 (+0.23), EUFN: 17.52 (-0.81)

Europe and Long-term Treasury: 2 ETFs to Watch on Outsized Volume
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 8:10AM CST
EUFN and TLO saw massive trading volumes in yesterday session.
SPY: 210.07 (-2.01), QQQ: 108.94 (-1.25), TLO: 77.55 (+0.31), DIA: 178.71 (-1.17), EUFN: 17.52 (-0.81)

Bank ETFs in Trouble?
Zacks Equity Research - Zacks Investment Research - Wed Feb 03, 12:49PM CST
With the global banking sector witnessing a steep sell-off lately, is this the time to stay away from bank ETFs?
KRE: 40.53 (-0.57), KBE: 32.24 (-0.53), GS: 149.89 (-3.28), KBWB: 35.23 (-0.57), JMP: 5.42 (+0.01), C: 43.90 (-1.11), EUFN: 17.52 (-0.81), WFC: 48.34 (-0.80), MS: 25.54 (-0.54)

BUYINS.NET: EUFN, CLDT, FN, QLIK, ANAC, ELA Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jan 19, 6:36AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Ishares MSCI Europe Financials Sector Index Fund (NASDAQ:EUFN), Chatham Lodging Trust (NYSE:CLDT), First National Financial Services Ltd (NYSE:FN), Qlik Technologies Inc (NASDAQ:QLIK), Anacor Pharmaceuticals Inc (NASDAQ:ANAC), (NYSE:ELA) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CLDT: 21.10 (-0.19), ELA: 25.24 (-0.29), FN: 36.57 (-1.32), QLIK: 30.00 (-0.06), EUFN: 17.52 (-0.81), ANAC: 99.17 (+0.09)

Bad Loans Problematic for European Bank ETF
ETFtrends.com - ETF Trends - Wed Nov 25, 6:30AM CST
While U.S. banks saw profitability surge in the third quarter and investors are displaying renewed enthusiasm for these stocks and exchange traded funds ahead of December’s Federal Reserve meeting, European banks remain hamstrung by bad loans....
EUFN: 17.52 (-0.81)

Time to Bank on European Banks
ETFtrends.com - ETF Trends - Tue Aug 18, 6:30AM CDT
All things considered, and those things include another bout of Greece’s financial ineptitude that again pushed the country to the brink of Eurozone expulsion, the iShares MSCI Europe Financials ETF (NYSEArca: EUFN ) has been remarkable this...
EUFN: 17.52 (-0.81)

ETFs to Access Stronger Overseas Developed Markets
ETFtrends.com - ETF Trends - Wed Jul 29, 3:30PM CDT
Developed international stocks and exchange traded funds are pulling ahead with the Eurozone strengthening on improved earnings and Japan finding support from domestic institutional investors. In Europe, with the Greek debt woes dissipating,...
FEZ: 32.60 (-1.20), IEFA: 53.22 (-1.53), HEFA: 23.82 (-0.56), EUFN: 17.52 (-0.81), EZU: 33.80 (-1.23), EWJ: 11.65 (-0.21), DXJ: 41.68 (-0.82), HEDJ: 51.52 (-1.47), HEWJ: 24.38 (-0.54), DBEF: 25.45 (-0.63), DBJP: 32.39 (-0.69), DBEZ: 24.50 (-0.78), EFA: 57.15 (-1.71), HEZU: 24.22 (-0.75)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 11

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 15

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 11

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 14

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 13

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 13

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 12

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation by Kahn Swick & Foti into Akero Therapeutics

Updated Category News Views 78

Kahn Swick & Foti Looks into Akero Therapeutics Kahn Swick & Foti, LLC has begun an investigation into Akero Therapeutics, Inc. (NASDAQ: AKRO), marking a significant event in the biopharmaceutical landscape. This action follows concerns related to the company's latest disclosures and how they might affect shareholders. An Overview of Akero Therapeutics Akero Therapeutics...

Continue Reading
Celebration of L.A. Film School Alumni at the Grammy Awards

Updated Category News Views 112

Celebrating the Success of L.A. Film School Alumni at the Grammy Awards Alumni from The L.A. Film School and L.A. Recording School have made a remarkable difference in the music industry, highlighted by their impressive achievements at the Grammy Awards. This year, they contributed to five Grammy-nominated projects, ultimately leading to eight prestigious wins. One...

Continue Reading
Bankers Insurance Transforms with Sapiens for Enhanced Growth

Updated Category News Views 107

Bankers Insurance Partners with Sapiens for Digital Transformation The specialty commercial carrier aims to enhance its operations by modernizing vital systems through Sapiens, focusing initially on builder's risk and business owner's policy, with plans to introduce additional products. Strategic Growth and Technology Modernization Bankers Insurance Group is embarking on...

Continue Reading
Hanmi Financial Reveals Upcoming Earnings Call Schedule

Updated Category News Views 136

Hanmi Financial Corporation's Upcoming Earnings Announcement Hanmi Financial Corporation (Nasdaq: HAFC), the parent company of Hanmi Bank, is preparing to share its financial results for the second quarter of 2025. This announcement is set to occur after the stock market closes on a Tuesday, on the 22nd of July. Following this release, the management team will engage with...

Continue Reading
Innovative Vehicle Disabling Device Enhances Law Enforcement Safety

Updated Category News Views 189

Transforming Vehicle Apprehension for Law Enforcement In the quest to keep communities safe, an inventive mind has introduced a groundbreaking product designed for police forces: the ROAD BLOCK. The genius behind this creation aimed to establish a method for apprehending thieves that prioritizes safety for both law enforcement officers and innocent civilians. Instead of...

Continue Reading